Bilateral breast cancer. Incidence and risk factors;Cancer du sein bilatéral. Incidence et facteurs de risque

Gynecologie Obstetrique et Fertilite

Volumn 32, Issue 2, 2004, Pages 128-134

  El Hanchi, Z ^a   Berrada, R ^a   Fadli, A ^a   Ferhati, D ^a   Brahmi, R ^a   Baydada, A ^a   Kharbach, A ^a   Chaoui, A ^a  

^a Maternité Univ Souissi M 1   (Tunisia)

Author keywords

Bilateral breast cancer; Cancer du sein bilat ral; Facteurs de risque; Prognosis; Pronostic; Risk factors

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PROGNOSIS; RISK FACTOR; WARD;

EID: 1442286073     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2003.01.002     Document Type: Article

References (34)

1. Fisher B. The Evolution of Paradigms for the Management of Breast Cancer: A Personal Perspective. Cancer Research. 52:1992;2371-2383.
2. Janschek E. Breast Cancer Res Treat. 67:2001;1-8.
3. Prior P., Waterhouse J.A.H. Incidence of bilateral tumours in a population-based series of breast-cancer patients: Two approaches to an epidemiological analysis. Br J Cancer. 37:1978;620-634.
4. Gollamudi S.V., Gelman R.S., Peiro G. Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer. 79:(7):1997;1362- 1369.
5. Mc Credie J.A., Inch W.R., Aiderson M. Consecutive primary carcinomas of the breast. Cancer. 35:1975;1472-1477.
6. Heron D.E., Komarnicky L.T., Hyslop T. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 88:(12):2000;2739-2750.
7. Chaudary M.A., Millis R.R., Hoskins E.O.L., Halder M. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg. 71:1984;711-714.
8. Newman L.A., Sahin A.A., Bondy M.L. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer. 91:(10):2001;1845-1853.
9. Bailley M.J., Royce C., Sloane P. Bilateral carcinoma of the breast. Br J Surg. 67:1980;514-516.
10. Stern E.E., Fletcher W.A. Bilateral cancer of the breast: A review of clinical, histologic, and immunohistologic characteristics. Surgery. 110:1991;617-622.
11. Urban J.A., Papchristou D., Taylor J. Bilateral breast cancer: biopsy of the opposite breast. Cancer. 40:1977;1968-1973.
12. Fracchia A.A., Robinson D., Legaspi A. Survival in Bilateral Breast Cancer. Cancer. 55:1985;1414-1421.
13. Gogas J., Markopoulos C.H., Skandalakis P. Bilateral Breast Cancer. The American Surgeon. 59:1993;733-735.
14. Fontaine F., Contesso G., Mouriesse H. Bilatéralisation des cancers du sein. Bull Cancer. 72:(2):1985;127-138.
15. Yeatman T.J., Lyman G.H., Smith S.K., Reintgen D.S. Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol. 4:(3):1997;198-202.
16. Raabe N.K., Sauer T., Erichsen A. Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer. Oncol Rep. 6:(5):1999;1001-1007.
17. Roudiboux M.A., Helvie M.A., Lai N.E. Bilateral Breast Cancer: Early Detection with Mammography. Radiology. 196:1995;427-431.
18. 0) patients with 20-year follow-up. Surgery. 1069:1989;904-910.
19. Hislop T.G., Elwood J.M., Coldman A.J. Second primary cancer of the breast: incidence and risk factors. Br J Cancer. 49:1984;79-85.
20. Slack N., Bross I.D.J. Experiences with bilateral primary carcinoma of the breast. Surgery Gynecol. Obstet. 136:1973;433-440.
21. Fisher E.R., Fisher B., Sass R. Pathologic findings from the National Adjuvant Breast Project. Bilateral Breast cancer. Cancer. 54:1984;3002-3011.
22. Anderson D.E., Badzioch M.D. Bilaterality in Familial Breast Cancer Patients. Cancer. 56:1985;2092-2098.
23. Harris R.E., Lynch H.T., Guirgis H.A. Familial breast cancer: Risk to the controlateral breast. J Natl Cancer Inst. 60:1978;955-960.
24. Mohamed S.N., Smith P., Hodgson S.V. Family history and survival in premenopausal breast cancer. Br J Cancer. 77:(12):1998;2252-2256.
25. Frykberg E.R. Lobular Carcinoma In Situ of the Breast. Breast J. 5:(5):1999;296-303.
26. Lesser M., Rosen P.P., Kinne D.W. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 91:(2):1982;234-240.
27. Webber B.L., Heise H., Neifeld J.P., Costa J. Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma. Cancer. 47:(12):1981;2928-2932.
28. Matsuo K., Fukutomi T., Tsuda H. Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma. J Surg Oncol. 77:(1):2001;31-34.
29. Anderson N., Lokich J. Bilateral Breast Cancer After Hodgkin's Disease. 65:1990;221-223.
30. Cutuli B., de la Rochefordière A., Dhermain F. Cancer du sein bilatéral après maladie de Hoggkin. Particularités clinicohistologiques et possibilités thérapeutiques: analyse de 13 cas. Cancer/Radiother. 1:1997;300-306.
31. Leis H.P. Selective, Elective, Prophylactic Controlateral Mastectomy. Cancer. 28:1971;956-961.
32. Pujol H. Prévenir le cancer du sein. Journal le sein. 9:2000;235-236.
33. Egan R.L. Bilateral breast carcinomas: role of mammography. Cancer. 38:1976;931-938.
34. Mose S., Adamietz I.A., Thilmann C. Bilateral breast carcinoma vs unilateral disease. Review of 498 patients. Am J Clin Oncol. 20:(6):1997;541-545.